Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind, Placebo-controlled, Parallel, Multicenter, Randomized Interventional Phase IV Study to Evaluate the Efficacy of Rotigotine on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

NCT01523301 is registered in ClinicalTrials.gov with UCB Korea Co., Ltd. as lead sponsor.

NCT NCT01523301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01523301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind, Placebo-controlled, Parallel, Multicenter, Randomized Interventional Phase IV Study to Evaluate the Efficacy of Rotigotine on Depressive Symptoms in Idiopathic Parkinson's Disease Patients
Lead sponsor
UCB Korea Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2012
Completion date
October 31, 2014
Enrollment
380 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson's disease